11:00 AM - 11:30 AM ET
Japan’s lucrative market opportunity for biotech
High reimbursement rates for innovative drugs. A sophisticated healthcare system with universal coverage and access to medicines like CAR-T. And a new government initiative prioritizing biotech as a key component of national policy makes Japan one of the most attractive places for drug developers to discover and market new products. Endpoints News founder Arsalan Arif sits down with Tadayuki Mizutani, the pharma head at Japan’s Ministry of Health, Labor and Welfare, to discuss the market opportunity. This session is for all biotech entrepreneurs, VCs, and pharma leaders.